Induction of hyperglycemia with insulin antibodies to B-chain determinants

• Published in: Diabetes (New York, N.Y.) Vol. 29; no. 5; pp. 383 - 390
• Main Authors: Kelso, J M, Tamai, I Y, Roth, M D, Valdes, I, Arquilla, E R
• Format: Journal Article
• Language: English
• Published: United States American Diabetes Association 01.05.1980
• Subjects: Animals; Antigen-Antibody Complex; Epitopes; Hemolysis; Hyperglycemia - etiology; Injections, Intraperitoneal; Insulin - immunology; Insulin Antibodies - analysis; Insulin, Long-Acting - immunology; Male; Mice; Proinsulin - immunology; Radioimmunoassay
• ISSN: 0012-1797; 1939-327X; 0012-1797
• DOI: 10.2337/diabetes.29.5.383

Induction of hyperglycemia with insulin antibodies to B-chain determinants. J M Kelso , I Y Tamai , M D Roth , I Valdes and E R Arquilla Abstract Insulin antibodies measured by a radioimmune method (ABR) are significantly better inducers of hyperglycemia than are insulin antibodies measured by an immune hemolysis method (ABH) when injected intraperitoneally into mice. The ability to induce hyperglycemia by an insulin antiserum can be predicted by the titer of ABR measured. ABR interact in vitro with determinants severely perturbed on nickel-insulin, partially perturbed on proinsulin and desasparagine-desalanine insulin, and unaffected on zinc-insulin or zinc-free monocomponent insulin. ABH, on the other hand, interact in vitro with determinants severely perturbed on proinsulin and desasparagine-desalanine insulin but stabilized on nickel-insulin and zinc-insulin. Since the connecting peptide of proinsulin is probably in apposition to the A-chain residues on the solvent surface, the more effective reaction of proinsulin with ABR than with ABH is submitted as evidence that ABR are directed toward residues on the B-chain surface of insulin. Because ABR are more effective inducers of hyperglycemia than are ABH, it is proposed that the degree of hyperglycemia induced by antibodies in vivo is a result of interactions with determinants on the B-chain surface of insulin. These results support the possibility that insulin in vivo is more accessible for interaction with antibodies directed to the B-chain of insulin. It is also possible that ABR, which are directed to B-chain determinants, are of higher affinity than is the affinity between insulin and receptors or that the active site of insulin for maintaining euglycemia includes the B-chain surface residues.